Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.
about
Genetic disorders coupled to ROS deficiencyPhysiological underpinnings of irritable bowel syndrome: neurohormonal mechanismsA combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome.An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-DRNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.Immune activation and gut microbes in irritable bowel syndrome.Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.Association of symptoms with gastrointestinal microbiota in irritable bowel syndromeMicrobiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.Irritable bowel syndrome: diagnostic approaches in clinical practice.Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome.Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment.Evaluation of gene expression classification studies: factors associated with classification performanceIrritable bowel syndrome, gut microbiota and probiotics.Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.The immune system in irritable bowel syndromeLocalization of the Dual Oxidase BLI-3 and Characterization of Its NADPH Oxidase Domain during Infection of Caenorhabditis elegans.Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.The effect of PDIA3 gene knockout on the mucosal immune function in IBS rats.PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity.When an Intramolecular Disulfide Bridge Governs the Interaction of DUOX2 with Its Partner DUOXA2Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome.Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform.The mucosal immune system: master regulator of bidirectional gut-brain communications.Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse IntestineAssociation of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot studyDual oxidases control release of hydrogen peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice.Current and novel therapeutic options for irritable bowel syndrome management.Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?Proteomics and irritable bowel syndrome.miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea.Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: is there hope?Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis.
P2860
Q26799545-2BB23A91-D9D4-4305-BE2B-3909C0DB4398Q26830683-CC21476C-4B96-4E2F-952D-BC2E16E5C238Q33457676-D47DA904-9C74-4FCE-8CD2-B0589D2D9B03Q33667183-0B6D4296-1ED5-4BF2-9800-25931ED0DD84Q33764582-487ACB9E-7EE2-44CC-AD53-F6B2FECB3F24Q33855474-1F0315E0-33CE-4746-A31C-17D5E9D96ED8Q33890449-FE044372-2BD0-47D8-AC43-ADCD0A07C902Q33987389-09A67ECF-5F89-4432-8CD2-57600F8974A2Q34155038-4683382F-2485-4D14-9F7E-55FFC85FBE59Q34960559-4868F06E-EAE2-42D4-9DD7-BF1EEDABB65EQ34992347-35B2C08A-D98C-45E0-8113-31EACD24737EQ35026362-C24101AF-7305-47A9-824E-F1B5F0FE7463Q35095269-7FEA831D-2FDC-483C-BFD1-77668E5988A3Q35120008-172DC51F-9CEF-462B-B686-F2475C1E7B3AQ35158226-DF973099-447E-4382-B25E-5BF88A9E48F5Q35161373-64EEB78A-0AAC-4BE5-B1C8-0322F9D10C4DQ35214374-61695074-5AE5-4F23-861B-A10893DED8F2Q35587508-1932429E-1EB8-4D8C-9AF4-5A5E2834722AQ35613687-CECF912D-4484-40A3-BB16-BF23C666ABD9Q35817782-7B653954-0333-4008-8179-4474512CD17EQ35870609-E53F4BE0-C4AB-4B93-9EB6-772C33751A50Q35964721-48503DEC-1951-41F1-BFD9-B975E4A33C97Q36086634-C2873601-59BB-48A9-85EB-957F823137E6Q36113266-74448FF3-E6D6-4312-A9B3-D62054888359Q36215720-4F4CE42B-D118-4234-AAC4-76A41D9D590AQ36252032-ECD7B77C-A8E6-431B-86EA-7105F8E43411Q36328418-0E4C0E8D-1A86-4BB7-8C21-4FC73964F2C1Q36494385-1D5F725C-BC80-4B25-BC1F-FA14B60B9651Q36568992-60AE948D-D2CD-4428-AEE7-1F9E8956E293Q37248764-7788C659-B84C-413F-A88E-1FF75DC7E871Q37438547-33B93688-4092-4904-9D7A-233289D41790Q37575689-2924C92D-EAC8-4BC1-AD04-8E444BC7C4BFQ37871421-5134F2B1-F85F-4198-B866-46FEA70C23B5Q38104610-13C1FA1E-7EE6-46B2-A3E4-26B19372CC6DQ39232397-0AFABF4D-6A68-4F44-87EE-DDD22B1EE2F5Q40373925-64006BDE-2E9D-4238-AC8D-1691D706ABCBQ41172853-FDA6CB62-AE07-4BDC-93A2-A2E75AA8DFA3Q41546077-91DE5494-3535-4EB3-B42F-858700D06B6AQ42967808-F0D88331-6F98-44DC-B72E-B59D2FC8CF85Q44000891-5C190F20-D6E5-4166-9C3A-FBF8F6ACD5B3
P2860
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@ast
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@en
type
label
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@ast
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@en
prefLabel
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@ast
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@en
P2093
P2860
P50
P1476
Alterations in mucosal immunit ...... with irritable bowel syndrome.
@en
P2093
Bernard Coulie
Christopher N Andrews
Duane D Burton
Hinrich W H Göhlmann
Ilse Van Den Wyngaert
Irene Busciglio
Jeroen Aerssens
Leen Thielemans
Paula J Carlson
Raul Urrutia
P2860
P304
P356
10.1016/J.CGH.2007.11.012
P407
P577
2008-02-01T00:00:00Z